Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Agonist Binding Reshapes the Kinetic Landscape and Allosteric Communication of APLNR Toward Activation-Competent States. | Int J Mol Sci | 2026 | 42737571 | PubTator, text mining | PubMed |
| A 3D in vitro co-culture model to investigate tumor-endothelial interactions in Neurofibromatosis type 2-associated meningiomas. | Neurooncol Adv | 2026 | 42730193 | PubTator, text mining | PubMed |
| The Role of High Serum Apelin Levels Within the First 24 h in Predicting 28-Day and Long-Term Mortality in Ischemic Cerebrovascular Disease. | J Clin Med | 2026 | 42652872 | PubTator, text mining | PubMed |
| The apelin/APJ signaling axis in ocular neurovascular disorders: Molecular mechanisms and therapeutic strategies for angiogenesis and neurodegeneration. | Biomed Pharmacother | 2026 | 42623845 | PubTator, text mining | PubMed |
| A Novel Ocular Fibrosis Signature for AMD Using the Two-Stage Laser-Induced Subretinal Fibrosis Mouse Model. | Invest Ophthalmol Vis Sci | 2026 | 42615798 | PubTator, text mining | PubMed |
| Structure-based design of non-hypertrophic apelin receptor modulator. | Cell | 2026 | 42561932 | PubTator, text mining | PubMed |
| The Apelin-APJ Axis in Heart Failure: Mechanistic Insights, Clinical Evidence, and Translational Challenges. | Cardiovasc Drugs Ther | 2026 | 42455245 | PubTator, text mining | PubMed |
| Apelin, Cortisol, and Doxorubicin-Induced Cardiotoxicity: A Triangle of Actions. | Cells | 2026 | 42439664 | PubTator, text mining | PubMed |
| The chemokine receptor-like fourth extracellular loop of the apelin receptor differentially regulates apelin and elabela binding and signalling. | Br J Pharmacol | 2026 | 42399569 | PubTator, text mining | PubMed |
| Apelin-APLNR pathway across development, inflammation, and vascular remodeling: an endothelial perspective. | Exp Mol Med | 2026 | 42393311 | PubTator, text mining | PubMed |
| Apelin receptor antagonist (ML221) facilitates memory reconsolidation in novel object recognition task. | Physiol Behav | 2026 | 42385866 | PubTator, text mining | PubMed |
| High-Efficiency Plasma Remediation of Petroleum Wastewater: A Comparison of Gliding Arc and Dielectric Barrier Discharge Air Plasma Jet. | Water Environ Res | 2026 | 42376959 | PubTator, text mining | PubMed |
| Elabela in Lipid-Related Cardiometabolic Dysfunction: A Critical Narrative Review. | Metabolites | 2026 | 42346388 | PubTator, text mining | PubMed |
| Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy. | J Adv Res | 2026 | 42324018 | PubTator, text mining | PubMed |
| Determination of the relationship between thymoquinone and apelin in isoproterenol-induced myocardial infarction. | Tissue Cell | 2026 | 42229283 | PubTator, text mining | PubMed |
| Role of Apelin in Type II Diabetes Mellitus. | Cureus | 2026 | 42211608 | PubTator, text mining | PubMed |
| Reduced plasma APJ levels and APLNR G212A polymorphism in Syrian patients with coronary artery disease. | Curr Med Res Opin | 2026 | 42207182 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-carboxamides as apelin receptor agonists. | Bioorg Med Chem Lett | 2026 | 42142713 | PubTator, text mining | PubMed |
| Placental apelin expression is low in early-onset fetal growth restriction but there is no association between maternal circulating apelin and pregnancy outcome. | Placenta | 2026 | 42061341 | PubTator, text mining | PubMed |
| Transient production of CD157-positive vascular endothelial stem-like cells during human-induced pluripotent stem cell-derived endothelial maturation. | Stem Cell Res | 2026 | 42030612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers